Hydroxylated iodinated boron clusters: a tunable platform for enhanced membrane transport and biocompatibility

Abstract

[B12I12]2− exhibits potent membrane transport yet high cytotoxicity. Stepwise hydroxylation moderates chaotropicity, balancing permeability and biocompatibility. Notably, mono-hydroxylation retains transport activity while minimizing toxicity, whereas further hydroxylation ablates permeability. This strategy advances safe, efficient boron cluster-based carriers for drug delivery and related biomedical applications.

Graphical abstract: Hydroxylated iodinated boron clusters: a tunable platform for enhanced membrane transport and biocompatibility

Supplementary files

Article information

Article type
Communication
Submitted
19 Jul 2025
Accepted
08 Sep 2025
First published
10 Dec 2025

Chem. Commun., 2026, Advance Article

Hydroxylated iodinated boron clusters: a tunable platform for enhanced membrane transport and biocompatibility

S. Yamamoto, R. Nakajima, Y. Hirai, Y. K. Kawamura, Y. Makita, T. Kitazawa, M. Kimura and Y. Kitazawa, Chem. Commun., 2026, Advance Article , DOI: 10.1039/D5CC04085J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements